FIELD: biotechnology.
SUBSTANCE: method includes obtaining of expression plasmid vector pET-rEPA (SEQ NO: 3), containing a promotor sequence of T7 bacteriophage DNA and DNA sequences encoding the N-end region of protein product of translation enhancer (MASMT amino-acid sequence), six histidine residues, site of SUMO protease cleavage and a sequence (SEQ NO: 1) optimized for broadcasting in E. coli encoding recombinant rEPA protein (SEQ NO: 2). Recombinant chimeric precursor protein in the heterological expression system in electro-competent cells of E. coli BL21 (DE3), transformed by the plasmid vector pET-rEPA to obtain a E. coli BL-rEPA strain at 37°C to ensure the maximum amount of accumulation of precursor protein in the soluble fraction. Lysis of the bacterial mass is carried out in the presence of 4% Triton X-100 to preserve the precursor protein in a soluble form. The precursor protein is isolated by metal chelate chromatography on Talon sorbent charged with Co2+ ions, followed by hexahistidine and SUMO peptide cleavage with SUMO protease from the polypeptide. The cleaved recombinant protein rEPA is subject to finish purification by anion-exchange chromatography on DEAE-Sepharose sorbent and gel-filtration chromatography on a Superdex 200-filled column, with translation to the target buffer with pH of 7.5, obtaining the recombinant rEPA protein.
EFFECT: production of protein in high yield.
4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING OF RECOMBINANT PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN (PAL) LEGIONELLA PNEUMOPHILA | 2016 |
|
RU2634385C1 |
EXPRESSION SYSTEM AND METHOD OF PRODUCING NON-MODIFIED RECOMBINANT PROTEINS IN Escherichia coli USING IT | 2015 |
|
RU2604796C1 |
METHOD TO OBTAIN CHEMERIC RECOMBINANT PROTEIN fliC:pagN | 2015 |
|
RU2627602C2 |
METHOD FOR BACTERIAL LIPOPOLYSACCHARIDES RECOMBINANT PHOSPHATASE PRODUCING | 2015 |
|
RU2617934C1 |
RECOMBINANT PLASMID DNA PSMT3_HCRG21 ENCODING A HYBRID PROTEIN SMT3-HCRG21, BACTERIAL STRAIN ESCHERICHIA COLI BL21(DE3)/PSMT3_HCRG21 - PRODUCER OF HCRG21 ANALGESIC PEPTIDE AND METHOD OF PRODUCING RECOMBINANT HCRG21 ANALGESIC PEPTIDE | 2022 |
|
RU2798545C1 |
RECOMBINANT PLASMID DNA pPHOFus CODING ANTHRAX LETHAL FACTOR SUBSTRATUM FUSED WITH ALKALINE PHOSPHATASE Escherichia coli, AND Escherichia coli BL-PHOFus STRAIN PRODUCING ANTHRAX LETHAL FACTOR PROTEIN SUBSTRATUM AS INGREDIENT OF ALKALINE PHOSPHATASE Escherichia coli | 2009 |
|
RU2416637C1 |
RECOMBINANT CHIMERIC PROTEIN SUMO3-apoA-I FOR PRODUCING MATURE HUMAN APOLIPOPROTEIN A-I, Pichia pastoris YEAST STRAIN - PRODUCER OF RECOMBINANT CHIMERIC PROTEIN SUMO3-apoA-I AND METHOD OF PRODUCING MATURE HUMAN APOLIPOPROTEIN A-I | 2015 |
|
RU2605326C1 |
METHOD FOR PRODUCING RECOMBINANT CAS13A-NUCLEASE WITH COLLATERAL ACTIVITY | 2020 |
|
RU2750816C1 |
RECOMBINANT PLASMID DNA pPA-OPRF-ETA CODING SYNTHESIS OF RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa, STRAIN Escherichia coli PA-OPRF-ETA PRODUCING RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa AND METHOD FOR PREPARING RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa | 2012 |
|
RU2529359C2 |
METHOD OF PRODUCING AND PURIFYING FUNCTIONALLY ACTIVE RECOMBINANT NSP1 SARS-CoV-2 PROTEIN AND METHOD OF IDENTIFYING POTENTIAL ANTI-COVID-19 DRUG COMPOUNDS AIMED AT INHIBITING NSP1 | 2021 |
|
RU2822761C2 |
Authors
Dates
2017-11-22—Published
2016-07-01—Filed